Sinopharm Group Overview

  • Status
  • Public
  • Employees
  • 98,234
Employees
  • Stock Symbol
  • 01099
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $2.39
  • (As of Thursday Closing)

Sinopharm Group General Information

Description

Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 80% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 15% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Sinopharm Plaza
  • No. 1001 Zhongshan Road (West), Changning District
  • Shanghai, 200051
  • China
+86 00000000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinopharm Group Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.39 $2.40 $1.89 - $3.80 $7.47B 2.97B 12.2M $0.31

Sinopharm Group Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 7,988,158 10,854,789 18,799,287 17,599,926
Revenue 60,728,792 61,517,064 52,046,832 45,498,591
EBITDA 2,565,569 2,865,420 2,442,713 2,106,250
Net Income 877,650 904,995 882,176 825,041
Total Assets 43,199,363 38,573,115 34,274,034 29,208,524
Total Debt 12,442,536 7,880,639 8,010,513 5,704,552
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sinopharm Group Board Members (1)

Name Representing Role Since
0000 000000 Self Vice Chairman 000 0000
To view Sinopharm Group’s complete board members history, request access »

Sinopharm Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinopharm Group Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 01-May-2019 00000 00000 00 000.00 Discovery Tools (Healthcare)
00000 00000000 000 20-Jul-2016 000000000000000000 00000 Pharmaceuticals 0000 000000
000000000 0000000 17-Sep-2015 000000000 00000000 000.00 Other Healthcare 0000 000000
00000000 000 00 00 11-Dec-2014 000000000 00000 00 000.00 Buildings and Property
Sichuan Medicine Company 18-Aug-2014 Secondary Transaction - Private 00000 Pharmaceuticals
To view Sinopharm Group’s complete investments and acquisitions history, request access »

Sinopharm Group Subsidiaries (3)

Company Name Industry Location Founded
China National Medicines Corporation Pharmaceuticals Beijing, China 1999
00000 00000000 000 PE/Buyout Beijing, China
000000000 0000000 Venture Capital Shanghai, China
To view Sinopharm Group’s complete subsidiaries history, request access »